Colforsin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 138605-00-2 |
PubChem (CID) | 444028 |
ChemSpider | 392052 |
UNII | 1F7A44V6OU |
KEGG | D01697 |
ChEMBL | CHEMBL52606 |
ECHA InfoCard | 100.215.763 |
Chemical and physical data | |
Formula | C27H43NO8 |
Molar mass | 509.631 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Colforsin (INN) is a water-soluble derivative of forskolin.[1]
References
- Mori M, Takeuchi M, Takaoka H, Hata K, Hayashi Y, Yokoyama M (August 1994). "Effect of NKH477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine". J. Cardiovasc. Pharmacol. 24 (2): 310–6. doi:10.1097/00005344-199424020-00018. PMID 7526066.
- Sanbe A, Takeo S (July 1995). "Effects of NKH477, a water-soluble forskolin derivative, on cardiac function in rats with chronic heart failure after myocardial infarction". J. Pharmacol. Exp. Ther. 274 (1): 120–6. PMID 7616388.
This article is issued from Wikipedia - version of the 5/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.